; (2) determine the appropriateness of the list of such medical conditions as of the date of enactment of this Act; (3) assess the special issuance process; (4) determine the appropriateness of whether a renewal of a special issuance can be based on a medical evaluation and treatment plan by the treating medical specialist of the individual pursuant to approval from an Aviation Medical Examiner; (5) evaluate advancements in technologies to address forms of red-green color blindness and determine whether such technologies may be approved for use by airmen; (6) review policies and guidance relating to Attention-Deficit Hyperactivity Disorder and Attention Deficit Disorder; (7) evaluate whether medications used to treat such disorders may be safely prescribed to airmen; (8) review protocols pertaining to the Human Intervention Motivation Study of the FAA; (9) review protocols and policies relating to— (A) neurological disorders; and (B) cardiovascular conditions to ensure alignment with medical best practices, latest research; (10) review mental health protocols and medications approved for treating such mental health conditions, including such actions taken resulting from recommendations by the Mental Health and Aviation Medical Clearances Rulemaking Committee; (11) assess processes and protocols pertaining to recertification of airmen receiving disability insurance post-recovery from the medical condition, injury, or disability that precludes airmen from exercising the privileges of an airman certificate; (12) assess processes and protocols pertaining to the certification of veterans reporting a disability rating from the Department of Veterans Affairs